
The robust clinical activity of zzso and zzso for treatment of chronic zzso zzso gastrointestinal zzso tumors, and breast cancer has demonstrated that blocking zzso zzso zzso can alter the natural history of human zzso On the other hand, zzso zzso zzso have shown overall modest zzso The contrast in the development of these agents implies that both molecular target dependence and patient selection are essential for the successful outcome of this zzso We will contrast lessons derived from the development of zzso of zzso zzso zzso zzso and zzso highlight successes and limitations in the field, and propose new approaches for clinical development of zzso zzso inhibitor zzso 

